Share-based Payment Arrangement, Expense of LEXICON PHARMACEUTICALS, INC. from 30 Sep 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
LEXICON PHARMACEUTICALS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2011 to 30 Sep 2025.
  • LEXICON PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3,400,000, a 21% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $11,100,000, a 27% decline year-over-year.
  • LEXICON PHARMACEUTICALS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $13,500,000, a 5.6% decline from 2023.
  • LEXICON PHARMACEUTICALS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $14,300,000, a 24% increase from 2022.
  • LEXICON PHARMACEUTICALS, INC. annual Share-based Payment Arrangement, Expense for 2022 was $11,500,000, a 8.5% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

LEXICON PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,100,000 $3,400,000 +$600,000 +21% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $10,500,000 $3,200,000 -$1,700,000 -35% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $12,200,000 $3,000,000 -$1,300,000 -30% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $13,500,000 $1,500,000 -$1,700,000 -53% 01 Oct 2024 31 Dec 2024 10-K 07 Mar 2025 2024 FY
Q3 2024 $15,200,000 $2,800,000 -$1,100,000 -28% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $16,300,000 $4,900,000 +$1,100,000 +29% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $15,200,000 $4,300,000 +$900,000 +26% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $14,300,000 $3,200,000 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 $3,900,000 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $3,800,000 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 $3,400,000 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q3 2016 $1,900,000 +$200,000 +12% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 $2,000,000 +$200,000 +11% 01 Apr 2016 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $1,800,000 -$200,000 -10% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q3 2015 $1,700,000 +$200,000 +13% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 $1,800,000 $0 0% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $2,000,000 -$300,000 -13% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q3 2014 $1,500,000 -$300,000 -17% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 $1,800,000 -$100,000 -5.3% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $2,300,000 +$200,000 +9.5% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015 2015 Q1
Q3 2013 $1,800,000 +$200,000 +12% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 $1,900,000 +$300,000 +19% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 $2,100,000 +$400,000 +24% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q3 2012 $1,600,000 +$200,000 +14% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $1,600,000 01 Apr 2012 30 Jun 2012 10-Q 01 Aug 2013 2013 Q2
Q1 2012 $1,700,000 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q3 2011 $1,400,000 01 Jul 2011 30 Sep 2011 10-Q 07 Nov 2012 2012 Q3

LEXICON PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $13,500,000 -$800,000 -5.6% 01 Jan 2024 31 Dec 2024 10-K 07 Mar 2025 2024 FY
2023 $14,300,000 +$2,800,000 +24% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2025 2024 FY
2022 $11,500,000 +$900,000 +8.5% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2025 2024 FY
2021 $10,600,000 01 Jan 2021 31 Dec 2021 10-K 25 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.